Profund Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $566K | Sell |
19,697
-2,220
| -10% | -$63.8K | 0.02% | 435 |
|
|
2025
Q1 | $735K | Buy |
21,917
+5,032
| +30% | +$169K | 0.03% | 370 |
|
|
2024
Q4 | $863K | Sell |
16,885
-3,176
| -16% | -$162K | 0.03% | 322 |
|
|
2024
Q3 | $1.03M | Sell |
20,061
-1,406
| -7% | -$71.8K | 0.04% | 317 |
|
|
2024
Q2 | $962K | Sell |
21,467
-12,816
| -37% | -$574K | 0.04% | 308 |
|
|
2024
Q1 | $1.6M | Sell |
34,283
-5,851
| -15% | -$274K | 0.06% | 207 |
|
|
2023
Q4 | $1.43M | Buy |
40,134
+6,308
| +19% | +$224K | 0.06% | 254 |
|
|
2023
Q3 | $1.01M | Buy |
33,826
+8,230
| +32% | +$245K | 0.06% | 280 |
|
|
2023
Q2 | $461K | Buy |
25,596
+1,193
| +5% | +$21.5K | 0.02% | 540 |
|
|
2023
Q1 | $392K | Buy |
+24,403
| New | +$392K | 0.02% | 597 |
|